Literature DB >> 2488083

How to digitalize and to maintain optimal digoxin levels in congestive heart failure.

C Lambert1, J L Rouleau.   

Abstract

Due to the narrow therapeutic-to-toxic ratio of digoxin, numerous studies have been done to assess the optimal digoxin level in patients with congestive heart failure. A digoxin level of 0.7-1.5 ng/mL (or 0.9-2.0 nMol/L) is generally considered optimal, but even at these levels toxicity may occur in certain clinical situations such as severe pulmonary disease or when electrolyte or metabolic disturbances are present. The optimal daily maintenance dose of digoxin depends on the preparation given and can be calculated by the equation of Jelliffe, which is largely based on the creatinine clearance of the patient. The daily digoxin dose must also be adjusted to take into consideration disease processes or concomitant drug therapy that can alter the volume of distribution, the biotransformation, or the excretion of the drug.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2488083     DOI: 10.1007/bf00133199

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  57 in total

1.  The use of digitalis in patients with pulmonary disease.

Authors:  L H Green; T W Smith
Journal:  Ann Intern Med       Date:  1977-10       Impact factor: 25.391

2.  Relationship of heart rate to ventricular automaticity in dogs during ouabain administration.

Authors:  S M Wittenberg; P Gandel; P M Hogan; W Kreuzer; F J Klocke
Journal:  Circ Res       Date:  1972-02       Impact factor: 17.367

3.  Digitalis toxicity. II. The effect of metabolic alkalosis.

Authors:  M C Warren; R E Gianelly; S L Cutler; D C Harrison
Journal:  Am Heart J       Date:  1968-03       Impact factor: 4.749

4.  Administration of digoxin.

Authors:  R W Jelliffe
Journal:  Dis Chest       Date:  1969-07

5.  Insensitivity to digoxin associated with hypocalcemia.

Authors:  D Chopra; P Janson; C T Sawin
Journal:  N Engl J Med       Date:  1977-04-21       Impact factor: 91.245

6.  Effects of ouabain on coronary and systemic vascular resistance and myocardial oxygen consumption in patients without heart failure.

Authors:  H DeMots; S H Rahimtoola; J H McAnulty; G A Porter
Journal:  Am J Cardiol       Date:  1978-01       Impact factor: 2.778

7.  Correlative studies of serum digitalis levels and the arrhythmias of digitalis intoxication.

Authors:  W Shapiro
Journal:  Am J Cardiol       Date:  1978-05-01       Impact factor: 2.778

8.  Digoxin-like immunoreactivity in premature and full-term infants not receiving digoxin therapy.

Authors:  M R Pudek; D W Seccombe; M F Whitfield; E Ling
Journal:  N Engl J Med       Date:  1983-04-14       Impact factor: 91.245

Review 9.  Factors affecting tolerance to digitalis.

Authors:  B Surawicz
Journal:  J Am Coll Cardiol       Date:  1985-05       Impact factor: 24.094

Review 10.  Quinidine and digoxin. An important interaction.

Authors:  J T Bigger; E B Leahey
Journal:  Drugs       Date:  1982-09       Impact factor: 9.546

View more
  2 in total

Review 1.  Pharmacokinetic changes in patients with oedema.

Authors:  B Vrhovac; N Sarapa; I Bakran; M Huic; V Macolic-Sarinic; I Francetic; A Wolf-Coporda; F Plavsic
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

2.  Intermittent low-dose digoxin may be effective and safe in patients with chronic heart failure undergoing maintenance hemodialysis.

Authors:  Xiaozhao Li; Xiang Ao; Qiong Liu; Jinghua Yang; Weisheng Peng; Rong Tang; Yong Zhong; Ting Meng; Lu Gan; Qiaoling Zhou
Journal:  Exp Ther Med       Date:  2014-10-09       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.